BioXcel Therapeutics (BTAI) has had the highest return since August 1, 2025 by a micro-cap US stock, returning 285.5%.
| ASSET | % RETURN |
|---|---|
BioXcel Therapeutics (BTAI) | 285.54% |
Medirom Healthcare Technologies (MRM) | 134.23% |
Equillium (EQ) | 121.45% |
Thayer Ventures Acquisition (TVACW) | 113.14% |
Kindly (NAKA) | 103.13% |
Matinas BioPharma (MTNB) | 88.24% |
Airnet Technology (ANTE) | 85.05% |
mF International Limited Ordinary Shares (MFI) | 76.02% |
I-Mab (IMAB) | 72.12% |
Village Farms International (VFF) | 65% |
Aureus Greenway Holdings Inc Common Stock (AGH) | 59.67% |
Verb Technology (VERB) | 58.42% |
Visionary Education Technology (GV) | 56.67% |
Puma Biotechnology (PBYI) | 56.45% |
Evoke Pharma (EVOK) | 56.29% |
InfuSystems (INFU) | 56.08% |
Telos (TLS) | 54.8% |
Cognition Therapeutics (CGTX) | 54.58% |
5E Advanced Materials (FEAM) | 52.49% |
Alector (ALEC) | 51.7% |
Portage Biotech (PRTG) | 46.77% |
VivoPower International (VVPR) | 46.31% |
OneConstruction Group Limited Ordinary Shares (ONEG) | 46.14% |
Beauty Health (SKIN) | 45.39% |
Ucloudlink (UCL) | 44.36% |
Micro-cap stocks are treated as having a market cap of <= $300M.
